23.68 - 23.68
20.75 - 25.07
1.4K / 5.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
109.15%
Revenue growth exceeding 1.5x Insurance - Life median of 1.95%. Joel Greenblatt would verify if operating margins keep pace with this top-line surge.
109.15%
Gross profit growth exceeding 1.5x Insurance - Life median of 16.13%. Joel Greenblatt would check if cost advantages or brand equity drive this surge.
-34.76%
Negative EBIT growth while Insurance - Life median is 0.00%. Seth Klarman would check if external or internal factors caused the decline.
-34.76%
Negative operating income growth while Insurance - Life median is 0.00%. Seth Klarman would check if structural or cyclical issues are at play.
-45.09%
Negative net income growth while Insurance - Life median is -5.56%. Seth Klarman would investigate factors dragging net income down.
-45.10%
Negative EPS growth while Insurance - Life median is -2.44%. Seth Klarman would explore whether share dilution or profit declines are to blame.
-45.10%
Negative diluted EPS growth while Insurance - Life median is -2.44%. Seth Klarman would look for the cause: weakened profitability or heavier share issuance.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-9.19%
Negative OCF growth while Insurance - Life median is 0.00%. Seth Klarman would ask if accounting or macro issues hamper the firm specifically.
-9.19%
Negative FCF growth while Insurance - Life median is 0.00%. Seth Klarman would see if others in the industry are still generating positive expansions in free cash.
106.77%
10Y revenue/share CAGR exceeding 1.5x Insurance - Life median of 40.78%. Joel Greenblatt would verify if a unique moat or brand fosters outperformance over a decade.
-12.95%
Negative 5Y CAGR while Insurance - Life median is 0.00%. Seth Klarman would see if others are at least growing moderately, indicating a firm-specific problem.
-10.23%
Negative 3Y CAGR while Insurance - Life median is -9.92%. Seth Klarman would examine if the sector is otherwise stable, indicating a company-specific issue.
8935.10%
OCF/share CAGR exceeding 1.5x Insurance - Life median of 62.87% over 10 years. Joel Greenblatt would verify if a unique competitive moat underlies these cash flows.
38.16%
5Y OCF/share growth exceeding 1.5x Insurance - Life median of 9.20%. Joel Greenblatt might see a strong moat or efficient cost structure driving outperformance.
223.96%
3Y OCF/share growth of 223.96% while Insurance - Life median is zero. Walter Schloss might see a modest advantage that could compound if momentum holds.
259.51%
Net income/share CAGR exceeding 1.5x Insurance - Life median of 94.92% over a decade. Joel Greenblatt might see a standout compounder of earnings.
3.73%
Positive 5Y CAGR while Insurance - Life median is negative. Peter Lynch sees a notable advantage vs. peers struggling to grow net income/share.
14.40%
Positive 3Y CAGR while Insurance - Life median is negative. Peter Lynch sees a big short-term advantage vs. peers struggling with profit declines.
196.88%
Equity/share CAGR exceeding 1.5x Insurance - Life median of 53.67% over 10 years. Joel Greenblatt would see if a high ROE underlies this compounding advantage.
0.43%
5Y equity/share CAGR near Insurance - Life median. Charlie Munger finds it normal mid-term expansion for the industry.
-1.80%
Negative 3Y equity/share growth while Insurance - Life median is 0.00%. Seth Klarman sees a short-term weakness if peers still expand net worth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
94.51%
Asset growth exceeding 1.5x Insurance - Life median of 2.80%. Joel Greenblatt confirms strong expansions matched by adequate returns on those assets.
-6.55%
Negative BV/share change while Insurance - Life median is 0.00%. Seth Klarman sees a firm-specific weakness if peers accumulate net worth.
-9.58%
Debt is shrinking while Insurance - Life median is rising. Seth Klarman might see an advantage if growth remains possible.
No Data
No Data available this quarter, please select a different quarter.
-7.13%
SG&A decline while Insurance - Life grows. Seth Klarman sees potential cost advantage or a risk if it hurts future growth.